ArticleUpdates in surgery2026
Novel side-to-end anastomosis as an alternative in ileocecal Crohn's disease - an observational study.
Article in Updates in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crohn's disease (CD) is characterized by periods of remission and recurrence. In patients who have undergone surgery, recurrence most often occurs at the anastomosis site or in the small intestine proximal to the anastomosis. The aim of the study is to evaluate early and long-term results of treatment in patients with ileocecal CD who underwent ileocecal resection and primary side-to-end anastomosis. The study included patients who underwent primary ileocecal resection with the novel side-to-end anastomosis. The study is a retrospective analysis conducted at a single high-volume center. The analysis included a group of 122 patients (71 women, mean age 34±11 years) with ileocecal CD. Anastomotic leakage was found in5 patients (4.0%). The observation period was 79 months (65-90). Surgical recurrence was observed in 5.6% of patients, and endoscopic recurrence in 9.0% of patients. Side-to-end anastomosis after ileocecal resection in patients with CD is safe and associated with a low risk of disease recurrence, even in the long term. In our opinion, the presented anastomosis can be considered in this group of patients. Our study is the first one to describe early and long-term results after this type of anastomosis in patients; however, it needs further prospective comparative studies.
Indexed as
Identifiers
42816742What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.